December 11, 2013
Deputy Commissioner of the FDA, Sally Howard, recently spoke on the topic of “FDA at the Crossroads” at a presentation to the Bioresearch Central Summit in Kansas City, MO.  Topics included the scope of the FDA, recent public health and innovative program successes, and a roadmap of high-priority future initiatives.  Key points and additional details about FDA’s current programs are highlighted here.